Pseudouridine Market, By Product Type (Chemistry) (Pseudouridine and N1-methylpseudouridine), By Purity (Research Grade (RUO), GMP / Clinical Grade, and Commercial / API Grade), By Form (Powder (lyophilized / crystalline) and Solution (aqueous / buffered)), By Application (mRNA Therapeutics (human), mRNA Vaccines (human), mRNA Veterinary (vaccines / therapeutics), Oligonucleotide / RNA Tools (controls, standards, probes), Cell & Gene Therapy Research (RNA engineering workflows), and Diagnostics & Assays (RNA-based kits, calibration materials)), By End User (Pharma & Biopharma Companies, CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish), CROs (preclinical/clinical support labs), Academic & Research Institutes, Government / Public Health Labs, and Diagnostic Companies), By Pack Size (Micro (≤100 mg), (Small (100 mg–1 g), Medium (1–25 g), and Bulk (25 g))), By Distribution Channel (Online and Offline), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)